RxDoctor Payments Data

Richard Granstein, MD

Dermatology · New York, NYNPI 1851488944

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,300 of the $1,348 with a category attached, or 96.4%. Galderma International SAS accounts for 96.4% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.

$1,348in general payments, 2019–2025

Across 3 payments — averaging $449.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma International SAS$1K
  • LEO Pharma Inc.$48
$1,301,170in research payments, 2019–2025

Across 43 payments — averaging $30,260 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1.1M
  • LEO Pharma AS$210K

What the payments were for

  • Consulting fees$1,30096%
  • Food & beverage$484%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma International SAS1$1,300
LEO Pharma Inc.2$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,348 in reported general payments places this provider in the 40th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York

Medicare billing

Part B allowed, 2024
$126,183
Medicare patients
250
Services billed
1,669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →